3.17
0.05 (1.6%)
0.05 (1.6%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Acer Therapeutics Inc | ACER | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.05 | 1.6% | 3.17 | 3.08 | 3.22 | 3.08 | 3.12 | 15:06:42 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 3.16 | 3.19 | 0.03 | 0.94% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 490 | 51,539 | $ 3.16 | $ 162,617 | 230,774 | 1.08 - 7.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:06:41 | 100 | $ 3.17 | USD |
Acer Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 32.49M | 10.25M | 5.68M | $ - | $ - | -2.91 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Acer Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACER Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.71 | 3.7883 | 3.05 | 3.24 | 147,980 | -0.54 | -14.56% |
| 1 Month | 3.17 | 4.37 | 2.86 | 3.55 | 282,985 | 0.00 | 0.0% |
| 3 Months | 2.07 | 7.05 | 1.35 | 3.48 | 204,094 | 1.10 | 53.14% |
| 6 Months | 3.84 | 7.25 | 1.08 | 3.44 | 137,913 | -0.67 | -17.45% |
| 1 Year | 3.45 | 7.25 | 1.08 | 3.28 | 118,021 | -0.28 | -8.12% |
| 3 Years | 8.55 | 34.10 | 1.08 | 8.45 | 80,778 | -5.38 | -62.92% |
| 5 Years | 8.55 | 34.10 | 1.08 | 8.45 | 80,778 | -5.38 | -62.92% |
Acer Therapeutics Description
| Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease. |
